MGAT5 | bioCADDIE Data Discovery Index
Mountain View
biomedical and healthCAre Data Discovery Index Ecosystem
help Advanced Search
Displaying 6 of 6 results for "MGAT5"
i
  1. The effect on cancer cells of the glycodendrimers believed to decrease tumor growth, prolong survival time, and enhance immune response ArrayExpress

    ID: E-GEOD-29936

    Description: nges in proliferation potential and expression of GnT-III and GnT-V in cancer cells in contrast to the peripheral blood mononuclear cells from healthy donors. As there are a sizable amount of enzymes involved in glycan metabolism and signaling pathways, the glyco-chip would be a very effective tool to determine which genes are involved in metabolism of these glycodendrimers. Our lab would like to develop expression profiles of cancer cells treated by glycodendrimers and a corresponding untreated control. For chip analyses we have chosen cell lines derived from chronic myeloid leukemia (K562), multiple myeloma (U266) and colon carcinoma (HT-29). There are untreated control samples an...

  2. MGT5A_MOUSE UniProt:Swiss-Prot

    ID: Q8R4G6

    Description: Alpha-1,6-mannosylglycoprotein 6-beta-N-acetylglucosaminyltransferase A Cy...

  3. MGT5A_RAT UniProt:Swiss-Prot

    ID: Q08834

    Description: Alpha-1,6-mannosylglycoprotein 6-beta-N-acetylglucosaminyltransferase A Cy...

  4. The effect on cancer cells of the glycodendrimers believed to decrease tumor growth, prolong survival time, and enhance immune response BioProject

    ID: PRJNA140885

    Keywords: Transcriptome or Gene expression

    Access Type: download

    dataset.description: nges in proliferation potential and expression of GnT-III and GnT-V in cancer cells in contrast to the peripheral blood mononuclear cells from healthy donors. As there are a sizable amount of enzymes involved in glycan metabolism and signaling pathways, the glyco-chip would be a very effective tool to determine which genes are involved in metabolism of these glycodendrimers. Our lab would like to develop expression profiles of cancer cells treated by glycodendrimers and a corresponding untreated control. Overall design: For chip analyses we have chosen cell lines derived from chronic myeloid leukemia (K562), multiple myeloma (U266) and colon carcinoma (HT-29). There are untreated co...
  5. The effect on cancer cells of the glycodendrimers believed to decrease tumor growth, prolong survival time, and enhance immune response OmicsDI

    ID: E-GEOD-29936

    Date Released: 06-27-2011

    Description: nges in proliferation potential and expression of GnT-III and GnT-V in cancer cells in contrast to the peripheral blood mononuclear cells from healthy donors. As there are a sizable amount of enzymes involved in glycan metabolism and signaling pathways, the glyco-chip would be a very effective tool to determine which genes are involved in metabolism of these glycodendrimers. Our lab would like to develop expression profiles of cancer cells treated by glycodendrimers and a corresponding untreated control. For chip analyses we have chosen cell lines derived from chronic myeloid leukemia (K562), multiple myeloma (U266) and colon carcinoma (HT-29). There are untreated control samples an...

  6. SPPL3 cleavage of glycosyltransferases regulates their activity OmicsDI

    ID: PXD001672

    Date Released: 05-08-2015

    Description: Golgi network. Recently, the key branching enzyme N-acetylglucosaminyltransferase V (GnT-V) and other medial/trans Golgi glycosyltransferases were identified as first physiological SPPL3 substrates. SPPL3-mediated endoproteolysis releases these enzymes from their type II membrane anchors resulting in a subsequent secretion of the respective enzymes’ ectodomain....


Displaying 6 of 6 results for "MGAT5"